arrow
Q

Qun Cheng

fudan university
H指数:20
被引数:889

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy of once-weekly teriparatide versus alendronate in Chinese postmenopausal osteoporosis: a randomised, open-label, active-controlled, 48-week, multicentre phase III study

每周一次特立帕肽与阿仑膦酸钠治疗中国绝经后骨质疏松症的疗效:一项随机、开放标签、活性对照、48周、多中心III期研究

2026-05-110
OAAI
Efficacy and safety of denosumab biosimilar CMAB807 versus Prolia® in Chinese postmenopausal women with osteoporosis

CMAB807(一种denosumab生物类似物)相对于Prolia®在患有骨质疏松的中国绝经后女性中的疗效与安全性

2025-09-190
PRE
Efficacy of generic teriparatide and alendronate in Chinese postmenopausal women with osteoporosis: a prospective study

特雷帕肽和阿仑膦酸钠对中国绝经后骨质疏松妇女的疗效: 一项前瞻性研究

2022-07-2815
OAAI
A phase III randomized, double-blind, placebo-controlled trial of the denosumab biosimilar QL1206 in postmenopausal Chinese women with osteoporosis and high fracture risk

denosumab生物仿制药QL1206在患有骨质疏松症和高骨折风险的绝经后中国妇女中的III期随机,双盲,安慰剂对照试验

2022-07-275
OA